Singapore’s recently opened S$2 million Nanyang Polytechnic (NYP) Centre of Excellence in Biologics Manufacturing features various Pall Biotech technologies for practical training and application.
The integrated biopharmaceutical training facility will introduce 300 NYP School of Chemical and Life Sciences students annually to the latest technologies and advances in the industry.
The NYP Centre of Excellence is showcasing single-use technologies, including chromatography column packing and filter integrity testing apparatus supplied by Pall Biotech. Each technology enables more thorough purification of substances in both biopharmaceutical and biologics processes, and helps students see the value of integrity in process.
“Large molecule drugs offer the potential to treat debilitating and life-threatening diseases in ways that were not possible before. Yet, to achieve this, manufacturing processes need to evolve for greater speed, reduced cost, and higher quality outputs,” said Steve Waters, vice president of Biotechnologies, Pall Biotech Asia. “The NYP Centre will benefit students and the wider Biotech industry through direct access to the latest technologies. Overall, the goal is to increase workforce skill levels in Singapore and its neighbouring countries.”
“We are proud to partner with Pall Biotech to bring the NYP students a deeper level of knowledge that comes only from the practical application of skills,” said Dr Joel Lee, Director of the NYP School of Chemical and Life Sciences. “It provides immense value to the students’ biologics and process technology, or chemical and pharmaceutical technology curriculum, giving them an excellent head-start for careers.”
The Centre complements the existing labs located at NYP with 120 training targets for industry professionals to learn the latest technologies as they grow in their careers. NYP also plans to support industry professionals with short industry courses on cell culture, sterilization techniques, and filtration technologies.
